Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > PPA and NPA - measures

<< Previous

Bullboard Posts

Next >>

Comment by stockmonster6on Feb 15, 2022 7:49am

90 Views

Post# 34429091

RE:RE:PPA and NPA - measures

Yes. So at least the test is valid enough for approval.

I've been searching and can't find it again - anyone have the link of what the minimum PPA and NPA % are for EUA approval?

I thought it was PPA of 80%, so we just barely squeaked by on that one.
I think the NPA was 90%, so the test did very well.

<< Previous

Bullboard Posts

Next >>

These cold weather stocks are looking to heat up for winter